newsfilter
← Latest News
FDA Approved Drugs·

Approval of Dupixent, Bla #761055

Approval Date: 07/15/2026; Drug Name: Dupixent, Bla #761055; Active Ingredients: DUPILUMAB; Company: Regeneron Pharmaceuticals; Submission Status: Approval; Application Number: 761055

Company
REGENERON PHARMACEUTICALS
Keywords
REGENERON PHARMACEUTICALS